Liaoning Chengda Biotechnology Company Description

Liaoning Chengda Biotechnology Co.,Ltd. a biotechnology company, engages in the research and development, production, and sales of vaccines for human use worldwide.

It offers inactivated Japanese encephalitis vaccine (IJEV) and SPEEDA-rabies vaccine. The company’s rabies and influenza vaccines are in the new drug application stage; haemophilus influenzae type b vaccine in phase III; recombinant human papillomavirus 15-valent vaccine is in phase II; and 13-valent pneumococcal polysaccharide conjugate and varicella, as well as the live meningococcal A, C, Y and W-135 conjugate vaccine are in phase I.

Its Serogroup B meningococcal outer membrane vesicle, 20-valent pneumococcal polysaccharide conjugate, recombinant zoster vaccine, multivalent HFMD (hand foot and mouth disease), high-dose influenza, and inactivated rabies monoclonal antibody vaccine are in the pre-clinical stage.

Liaoning Chengda Biotechnology Co.,Ltd. was founded in 2002 and is headquartered in Shenyang, China.

Liaoning Chengda Biotechnology Co.,Ltd. is a subsidiary of Liaoning Cheng Da Co., Ltd.

Liaoning Chengda Biotechnology Co.,Ltd.

Country	China
Founded	2002
Industry	Biotechnology
Sector	Healthcare
Employees	1,807
CEO	Yu Mao

Contact Details

Address: No. 1 Xinfang Street Shenyang, 110179 China
Phone	86 24 8378 2632
Website	cdbio.cn

Stock Details

Ticker Symbol	688739
Exchange	Shanghai Stock Exchange
Fiscal Year	January - December
Reporting Currency	CNY
SIC Code	2836

Key Executives

Name	Position
Yu Mao	GM and Director
Jianwei Cui	Deputy GM, Chief Financial Officer, Secretary, Accounting Supervisor and Director
Weiqiang Sun	Deputy GM and Chief Scientist
Junwei Yang	Deputy GM and Director
Xin Chen	Deputy General Manager
Deming Yuan	Deputy General Manager
Huanyu Wang	Deputy General Manager
Xu Li	Core Technical Personnel
Yin Chen	Core Technical Personnel
Song Yuan Yao	Core Technical Personnel